[Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
D000759:Adjuvants, Anesthesia / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D010096:Oxprenolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000759:Adjuvants, Anesthesia; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D010096:Oxprenolol; D011433:Propranolol